- Home
- ADVM vs MVST Comparison
ADVM vs MVST Comparison
Compare ADVM & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- MVST
- Stock Information
- Founded
- ADVM 2006
- MVST 2006
- Country
- ADVM United States
- MVST United States
- Employees
- ADVM N/A
- MVST N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- MVST Industrial Machinery/Components
- Sector
- ADVM Health Care
- MVST Miscellaneous
- Exchange
- ADVM Nasdaq
- MVST Nasdaq
- Market Cap
- ADVM 140.6M
- MVST 98.7M
- IPO Year
- ADVM 2014
- MVST N/A
- Fundamental
- Price
- ADVM $7.30
- MVST $0.31
- Analyst Decision
- ADVM Strong Buy
- MVST Buy
- Analyst Count
- ADVM 6
- MVST 4
- Target Price
- ADVM $28.17
- MVST $4.50
- AVG Volume (30 Days)
- ADVM 144.8K
- MVST 2.7M
- Earning Date
- ADVM 11-07-2024
- MVST 11-07-2024
- Dividend Yield
- ADVM N/A
- MVST N/A
- EPS Growth
- ADVM N/A
- MVST N/A
- EPS
- ADVM N/A
- MVST N/A
- Revenue
- ADVM N/A
- MVST $349,717,000.00
- Revenue This Year
- ADVM N/A
- MVST $28.09
- Revenue Next Year
- ADVM $5,848.83
- MVST $51.36
- P/E Ratio
- ADVM N/A
- MVST N/A
- Revenue Growth
- ADVM N/A
- MVST 55.20
- 52 Week Low
- ADVM $6.38
- MVST $0.18
- 52 Week High
- ADVM $29.70
- MVST $1.95
- Technical
- Relative Strength Index (RSI)
- ADVM 55.10
- MVST 55.75
- Support Level
- ADVM $6.54
- MVST $0.18
- Resistance Level
- ADVM $7.20
- MVST $0.28
- Average True Range (ATR)
- ADVM 0.35
- MVST 0.04
- MACD
- ADVM 0.06
- MVST 0.01
- Stochastic Oscillator
- ADVM 67.26
- MVST 71.00
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extend from core battery chemistry to battery packs.